Literature DB >> 15088144

Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

Christian G Sauer1, Alexandra Kappeler, Monika Späth, Jens J Kaden, Maurice S Michel, Doris Mayer, Uwe Bleyl, Rainer Grobholz.   

Abstract

Prostate cancer is the most common cancer in men and second in the cancer-related frequency of mortality. Matrix metalloproteinases (MMPs) are involved in tumor invasion and metastasis in various malignancies. MMP-2 and MMP-9 are capable of digesting collagen type IV. Numerous studies have demonstrated an association between increased MMP-2 and -9 expression and tumor progression in various tumors. In this study, the expression and activities of MMP-2 and -9 were assessed in serum probes and tumor tissue from core needle biopsies and radical prostatectomies of 97 patients. MMP-2 and -9 serum expression was analyzed in a subgroup of 31 patients. MMP-9 serum expression was significantly increased in tumor patients and correlated with tumor grade. In contrast, the MMP-9 tissue expression and activity revealed no significant correlations to tumor stage or grade. The MMP-2 activity, however, showed a positive correlation for MMP-2 with tumor stage. Increased activity was predominantly detected in advanced tumor stages. Immunohistochemical analysis of MMP-2 expression demonstrated a positive association with tumor grade in prostatectomy specimens. The relative expression rates in biopsies matched in 65% with those of the prostatectomies. Detection of MMP-2 in core needle biopsies seems not to be a helpful marker for diagnostic purposes. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15088144     DOI: 10.1007/s00428-004-1016-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  35 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

2.  Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.

Authors:  B L Lokeshwar; M G Selzer; N L Block; Z Gunja-Smith
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

Review 3.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

4.  Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.

Authors:  C Festuccia; M Bologna; C Vicentini; A Tacconelli; R Miano; S Violini; A R Mackay
Journal:  Int J Cancer       Date:  1996-10-21       Impact factor: 7.396

Review 5.  Histologic grading of prostate cancer: a perspective.

Authors:  D F Gleason
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

6.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

7.  Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension.

Authors:  K Gohji; N Fujimoto; I Hara; A Fujii; A Gotoh; H Okada; S Arakawa; S Kitazawa; H Miyake; S Kamidono; M Nakajima
Journal:  Int J Cancer       Date:  1998-02-20       Impact factor: 7.396

Review 8.  Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.

Authors:  S Zucker; M Hymowitz; C Conner; H M Zarrabi; A N Hurewitz; L Matrisian; D Boyd; G Nicolson; S Montana
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

9.  Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.

Authors:  V Knäuper; H Will; C López-Otin; B Smith; S J Atkinson; H Stanton; R M Hembry; G Murphy
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

10.  Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.

Authors:  Hisashi Ishimaru; Yukio Kageyama; Tetsuo Hayashi; Tetsuo Nemoto; Yoshinobu Eishi; Kazunori Kihara
Journal:  Acta Oncol       Date:  2002       Impact factor: 4.089

View more
  16 in total

1.  XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).

Authors:  Jui Pandhare-Dash; Chinmay K Mantri; Yuanying Gong; Zhenbang Chen; Chandravanu Dash
Journal:  Prostate       Date:  2011-09-19       Impact factor: 4.104

2.  Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

Authors:  Thomas P Lynch; Christina M Ferrer; S RaElle Jackson; Kristina S Shahriari; Keith Vosseller; Mauricio J Reginato
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.

Authors:  Jonathan M Fahey; Albert W Girotti
Journal:  Nitric Oxide       Date:  2015-06-09       Impact factor: 4.427

4.  Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3).

Authors:  M R Vijayababu; A Arunkumar; P Kanagaraj; P Venkataraman; G Krishnamoorthy; J Arunakaran
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

5.  Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis.

Authors:  Chunwa Jiang; Juanjing Wang; Chen Dong; Wei Wei; Jiang Li; Xiaomeng Li
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

6.  Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?

Authors:  Silvan Boxler; Valentin Djonov; Thomas M Kessler; Ruslan Hlushchuk; Lucas M Bachmann; Ulrike Held; Regula Markwalder; George N Thalmann
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

Review 7.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors:  Roopali Roy; Jiang Yang; Marsha A Moses
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 8.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

9.  Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.

Authors:  Ferhat Ozden; Caner Saygin; Didem Uzunaslan; Bulent Onal; Haydar Durak; Hilal Aki
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-25       Impact factor: 4.553

10.  Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?

Authors:  Francesca Carozzi; Lara Tamburrino; Simonetta Bisanzi; Sara Marchiani; Milena Paglierani; Simonetta Di Lollo; Emanuele Crocetti; Carlotta Buzzoni; Elena Burroni; Luana Greco; Elisabetta Baldi; Cristina Sani
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-26       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.